Article ; Online: Longitudinal Cognitive Decline in Alzheimer Disease Prevention Trials: A Test of Time
2023 Volume 102, Issue 2, Page(s) e208067
Abstract: The landscape of clinical trials for Alzheimer disease (AD) has undergone significant evolution in the past decade, most notably by the inclusion of individuals at progressively earlier stages of the disease. Recent approvals by the Food and Drug ... ...
Abstract | The landscape of clinical trials for Alzheimer disease (AD) has undergone significant evolution in the past decade, most notably by the inclusion of individuals at progressively earlier stages of the disease. Recent approvals by the Food and Drug Administration have predominantly centered around individuals with prodromal and mild AD, |
---|---|
MeSH term(s) | United States ; Humans ; Alzheimer Disease/prevention & control ; Cognitive Dysfunction/prevention & control ; Neuropsychological Tests ; Research Design ; Signal Transduction |
Language | English |
Publishing date | 2023-12-26 |
Publishing country | United States |
Document type | Editorial |
ZDB-ID | 207147-2 |
ISSN | 1526-632X ; 0028-3878 |
ISSN (online) | 1526-632X |
ISSN | 0028-3878 |
DOI | 10.1212/WNL.0000000000208067 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Ui II Zs.153: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
|||
Zs.MG 18: Show issues | ||||
Zs.MO 374: Show issues |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.